Global Novel Drugs and Devices to Lower Intraocular Pressure Market Restraints
Side effects of glaucoma medications are expected to hinder growth of the global novel drugs and devices to lower intraocular pressure market. Side effects of medications used for the treatment of glaucoma, such as Rhopressa, include internal bleeding, corneal deposits, and stinging. Also, the cost of these medications is very high. For instance, 2.5 milliliter’s of Rhopressa (Netarsudil ophthalmic solution) costs around US$269. Hence, these factors are expected to restrain the global novel drugs and devices to lower intraocular pressure market growth.
Novel Drugs And Devices To Lower Intraocular Pressure Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients